Related Experiment Video

Updated: May 13, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Disruption of E627 and R683 interaction is responsible for B-cell acute lymphoblastic leukemia caused by JAK2

Qing-Yun Wu1, Hua-Yan Guo, Feng Li

  • 1Department of Hematology, The Affiliated Hospital of Xuzhou Medical College , Xuzhou , China.

Leukemia & Lymphoma
|March 5, 2013
PubMed

Insights

Janus kinase 2 (JAK2) mutations disrupting autoinhibition cause constitutive activation, potentially driving B-cell acute lymphoblastic leukemia (B-ALL). Understanding this mechanism offers insights into JAK2 R683G(S) mutation-associated B-ALL.

Area of Science:

  • Molecular Biology
  • Hematology
  • Oncology

Background:

  • Janus kinase 2 (JAK2) is crucial for cytokine receptor signaling in hematopoietic and immune cells.
  • Acquired JAK2 R683G(S) mutations are biomarkers in 15% of B-cell acute lymphoblastic leukemia (B-ALL) cases.
  • The precise mechanism linking JAK2 R683G(S) mutations to B-ALL pathogenesis remains unclear.

Purpose of the Study:

  • To elucidate the role of the E627 and R683 interaction in JAK2 autoinhibition.
  • To investigate how JAK2 R683G(S) mutations affect JAK2 activity and B-ALL development.

Main Methods:

  • Investigated JAK2 autoinhibition through analyzing specific mutations (R683S, R683G, E627A, R683K, E627D).
  • Utilized spectroscopy to examine domain interactions and conformational changes in JAK2.
  • Assessed the impact of mutations on Ba/F3 cell proliferation.

Main Results:

  • Disruption of the E627-R683 interaction leads to JAK2 constitutive activation.
  • Mutations abolishing this interaction abolish JH1/JH2 domain interactions, promoting an active JAK2 conformation.
  • JAK2 mutations that disrupt E627-R683 interaction promote Ba/F3 cell proliferation.

Conclusions:

  • The E627-R683 interaction is vital for JAK2 autoinhibition.
  • Disruption of this interaction causes JAK2 activation and promotes cell proliferation, offering insights into JAK2 R683G(S) mutation-associated B-ALL.

More Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...